Evidence map›Paper›PMID 28919859›Full record

ArticleFrontiers in pharmacology2017

The Dietary Constituent Falcarindiol Promotes Cholesterol Efflux from THP-1 Macrophages by Increasing ABCA1 Gene Transcription and Protein Stability.

Limei Wang, Veronika Palme, Nicole Schilcher, Angela Ladurner, Elke H Heiss, Herbert Stangl, Rudolf Bauer, Verena M Dirsch, Atanas G Atanasov

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Role ofCurrent medicinal chemistry · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Limei WangDepartment of Pharmacognosy, University of ViennaVienna, Austria.
Veronika PalmeDepartment of Pharmacognosy, University of ViennaVienna, Austria.
Nicole SchilcherDepartment of Pharmacognosy, University of ViennaVienna, Austria.
Angela LadurnerDepartment of Pharmacognosy, University of ViennaVienna, Austria.
Elke H HeissDepartment of Pharmacognosy, University of ViennaVienna, Austria.
Herbert StanglCenter for Pathobiochemistry and Genetics, Institute of Medical Chemistry, Medical University of ViennaVienna, Austria.
Rudolf BauerDepartment of Pharmacognosy, Institute of Pharmaceutical Sciences, Karl-Franzens-University GrazGraz, Austria.
Verena M DirschDepartment of Pharmacognosy, University of ViennaVienna, Austria.
Atanas G AtanasovDepartment of Pharmacognosy, University of ViennaVienna, Austria.
University of Vienna · ATMedical University of Vienna · ATQingdao University · CNUniversity of Graz · AT

Funding

Austrian Science Fund FWF P 25971
6 · The paper itself

Abstract

We report increased cholesterol efflux from macrophages in the presence of falcarindiol, an important dietary constituent present in commonly used vegetables and medicinal plants. Falcarindiol (3-20 μM) increased cholesterol efflux from THP-1-derived macrophages. Western blot analysis showed an increased protein level of ABCA1 upon falcarindiol exposure. Quantitative real-time PCR revealed that also ABCA1 mRNA level rise with falcarindiol (10 μM) treatment. The effect of falcarindiol on ABCA1 protein as well as mRNA level were counteracted by co-treatment with BADGE, an antagonist of PPARγ. Furthermore, falcarindiol significantly inhibited ABCA1 protein degradation in the presence of cycloheximide. This post-translational regulation of ABCA1 by falcarindiol occurs most likely by inhibition of lysosomal cathepsins, resulting in decreased proteolysis and extended protein half-life of ABCA1. Taken together, falcarindiol increases ABCA1 protein level by two complementary mechanisms, i.e., promoting ABCA1 gene expression and inhibiting ABCA1 protein degradation, which lead to enhanced cholesterol efflux.

Indexed as

ABCA1cholesterol effluxfalcarindiolPPARγprotein degradation

Identifiers

PMID28919859
PMCPMC5585181
OpenAlexW2751810605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.